Show simple item record

dc.contributor.authorIghilahriz, Men
dc.contributor.authorBenfodda, Men
dc.contributor.authorSharpe, Hayleyen
dc.contributor.authorSoufir, Nen
dc.contributor.authorMourah, Sen
dc.contributor.authorDumaz, Nen
dc.contributor.authorBattistella, Men
dc.contributor.authorSavina, Aen
dc.contributor.authorBouquet, Fen
dc.contributor.authorNikolaev, Sen
dc.contributor.authorBasset-Seguin, Nen
dc.date.accessioned2019-07-16T23:31:00Z
dc.date.available2019-07-16T23:31:00Z
dc.date.issued2019-11en
dc.identifier.issn0926-9959
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/294698
dc.description.abstractHedgehog pathway inhibitors (HPI) inactivating SMO 1, have become first line treatment for patients with locally advanced BCC (laBCC). HPI safety and efficacy have been shown in clinical trials2,3. Nevertheless, common adverse events lead to treatment discontinuation.
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.publisherWiley
dc.rightsAll rights reserved
dc.subjectHumansen
dc.subjectCarcinoma, Basal Cellen
dc.subjectSkin Neoplasmsen
dc.subjectNeoplasm Recurrence, Localen
dc.subjectAnilidesen
dc.subjectPyridinesen
dc.subjectDrug Resistance, Neoplasmen
dc.subjectMutationen
dc.titleVismodegib resistant mutations are not selected in multifocal relapses of locally advanced basal cell carcinoma after vismodegib discontinuation.en
dc.typeArticle
prism.endingPagee424
prism.issueIdentifier11en
prism.publicationDate2019en
prism.publicationNameJournal of the European Academy of Dermatology and Venereology : JEADVen
prism.startingPagee422
prism.volume33en
dc.identifier.doi10.17863/CAM.41803
dcterms.dateAccepted2019-05-29en
rioxxterms.versionofrecord10.1111/jdv.15741en
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2019-11en
dc.contributor.orcidSharpe, Hayley [0000-0002-4723-298X]
dc.contributor.orcidDumaz, N [0000-0003-3511-2160]
dc.contributor.orcidBasset-Seguin, N [0000-0002-9136-1244]
dc.identifier.eissn1468-3083
rioxxterms.typeJournal Article/Reviewen
cam.orpheus.successThu Jan 30 10:41:54 GMT 2020 - Embargo updated*
rioxxterms.freetoread.startdate2020-11-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record